Lineage Cell Therapeutics Inc. (LCTX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Broadwood Capital

Neal C. Bradsher

34,935,485 $53,801 +3% 3.87%
2.
Two Sigma Advisors

John Overdeck And David Siegel

615,766 $948 -44% 0%
3.
Millennium Management

Israel Englander

178,493 $275 -47% 0%
4. 140,000 $216 +75% 0.05%
5. 56,003 $86 -77% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.53 6,400 Officer, Director 97,787 2022-03-31 Filing
$1.63 35,000 Director 35,000 2022-03-28 Filing
$1.38 5,250 Officer, Director 81,280 2022-03-25 Filing
$0.00 0 Large Shareholder, Director 34,935,485 2022-03-25 Filing
$1.44 470,000 Large Shareholder, Director 34,935,485 2022-03-25 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.44 28,445 Officer 0 2021-12-29 Filing
$2.49 9,250 Officer 28,445 2021-12-29 Filing
$2.45 501,588 Officer 28,445 2021-12-28 Filing
$2.93 19,142 Director 15,578 2021-06-29 Filing
$2.97 4,720 Director 87,500 2021-06-29 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 5,131,935 $8,108 3.18%
2. 1,000 $1,580 0%
3. 251,500 $397 0%
4. 247,735 $391 0%
5. 135,328 $214 0%
News See All